A Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of PRA-027 Administered Orally to Japanese Postmenopausal Women.

Trial Profile

A Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of PRA-027 Administered Orally to Japanese Postmenopausal Women.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs PRA 027 (Primary)
  • Indications Menopausal syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 05 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top